Sharma V, Pal J, Dashora V, Chattopadhyay S, Kapoor Y, Singha B
J Biol Chem. 2025; 301(3):108208.
PMID: 39842664
PMC: 11871502.
DOI: 10.1016/j.jbc.2025.108208.
Zhang Z, Li M, Hou Y, Huang T, Zhang B, Lin Q
J Biol Chem. 2024; 301(2):108134.
PMID: 39725038
PMC: 11791264.
DOI: 10.1016/j.jbc.2024.108134.
Nadiminti K, Sahasrabudhe K, Liu H
J Hematol Oncol. 2024; 17(1):113.
PMID: 39558390
PMC: 11575055.
DOI: 10.1186/s13045-024-01632-8.
Liang Q, Zhang S, Liu Z, Wang J, Yin H, Guan G
BMC Genomics. 2024; 25(1):804.
PMID: 39187768
PMC: 11346185.
DOI: 10.1186/s12864-024-10731-2.
Xu Q, La T, Ye K, Wang L, Wang S, Hu Y
Clin Transl Med. 2024; 14(6):e1734.
PMID: 38888967
PMC: 11185127.
DOI: 10.1002/ctm2.1734.
Novel variant associated with neurodevelopmental disorder in a Chinese family: A case report.
Tong J, Chen X, Wang X, Men S, Liu Y, Sun X
Heliyon. 2024; 10(7):e28686.
PMID: 38571636
PMC: 10988039.
DOI: 10.1016/j.heliyon.2024.e28686.
Epigenetic Modulators as Therapeutic Agents in Cancer.
Patnaik E, Madu C, Lu Y
Int J Mol Sci. 2023; 24(19).
PMID: 37834411
PMC: 10573652.
DOI: 10.3390/ijms241914964.
The Roles of Histone Lysine Methyltransferases in Heart Development and Disease.
Zhu J, van de Leemput J, Han Z
J Cardiovasc Dev Dis. 2023; 10(7).
PMID: 37504561
PMC: 10380575.
DOI: 10.3390/jcdd10070305.
Novel investigational approaches for high-risk genetic subsets of AML: TP53, KMT2A, FLT3.
Sahasrabudhe K, Mims A
Hematology Am Soc Hematol Educ Program. 2022; 2022(1):15-22.
PMID: 36485136
PMC: 9820850.
DOI: 10.1182/hematology.2022000325.
Zinc Finger Proteins: Functions and Mechanisms in Colon Cancer.
Liu S, Sima X, Liu X, Chen H
Cancers (Basel). 2022; 14(21).
PMID: 36358661
PMC: 9654003.
DOI: 10.3390/cancers14215242.
Exosomal telomerase transcripts reprogram the microRNA transcriptome profile of fibroblasts and partially contribute to CAF formation.
Likonen D, Pinchasi M, Beery E, Sarsor Z, Signorini L, Gervits A
Sci Rep. 2022; 12(1):16415.
PMID: 36180493
PMC: 9525320.
DOI: 10.1038/s41598-022-20186-8.
The Epigenetic Regulation of Nonhistone Proteins by SETD7: New Targets in Cancer.
Chiang C, Yang H, Zhu L, Chen C, Chen C, Zuo Y
Front Genet. 2022; 13:918509.
PMID: 35812730
PMC: 9256981.
DOI: 10.3389/fgene.2022.918509.
Lysine methyltransferase inhibitors: where we are now.
Feoli A, Viviano M, Cipriano A, Milite C, Castellano S, Sbardella G
RSC Chem Biol. 2022; 3(4):359-406.
PMID: 35441141
PMC: 8985178.
DOI: 10.1039/d1cb00196e.
The Role of Lysine Methyltransferase SET7/9 in Proliferation and Cell Stress Response.
Daks A, Vasileva E, Fedorova O, Shuvalov O, Barlev N
Life (Basel). 2022; 12(3).
PMID: 35330113
PMC: 8949485.
DOI: 10.3390/life12030362.
Structures and biological functions of zinc finger proteins and their roles in hepatocellular carcinoma.
Li X, Han M, Zhang H, Liu F, Pan Y, Zhu J
Biomark Res. 2022; 10(1):2.
PMID: 35000617
PMC: 8744215.
DOI: 10.1186/s40364-021-00345-1.
Methylation-directed acetylation of histone H3 regulates developmental sensitivity to histone deacetylase inhibition.
Huang L, Hsu D, Pears C
Nucleic Acids Res. 2021; 49(7):3781-3795.
PMID: 33721015
PMC: 8053100.
DOI: 10.1093/nar/gkab154.
The WNT/β-catenin dependent transcription: A tissue-specific business.
Soderholm S, Cantu C
WIREs Mech Dis. 2020; 13(3):e1511.
PMID: 33085215
PMC: 9285942.
DOI: 10.1002/wsbm.1511.
New insights into the activities and toxicities of the old anticancer drug doxorubicin.
van der Zanden S, Qiao X, Neefjes J
FEBS J. 2020; 288(21):6095-6111.
PMID: 33022843
PMC: 8597086.
DOI: 10.1111/febs.15583.
The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review.
Rugo H, Jacobs I, Sharma S, Scappaticci F, Paul T, Jensen-Pergakes K
Adv Ther. 2020; 37(7):3059-3082.
PMID: 32445185
PMC: 7467409.
DOI: 10.1007/s12325-020-01379-x.
Characterization of the Menin-MLL Interaction as Therapeutic Cancer Target.
Brzezinka K, Nevedomskaya E, Lesche R, Haegebarth A, Ter Laak A, Fernandez-Montalvan A
Cancers (Basel). 2020; 12(1).
PMID: 31947537
PMC: 7016952.
DOI: 10.3390/cancers12010201.